NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 42 filers reported holding NEXTCURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $473,206 | -28.4% | 366,826 | -0.0% | 0.00% | -50.0% |
| Q2 2023 | $660,508 | +14.9% | 366,949 | -5.6% | 0.00% | +100.0% |
| Q1 2023 | $575,082 | +4.8% | 388,569 | -0.1% | 0.00% | -50.0% |
| Q4 2022 | $548,518 | -62.0% | 389,020 | -26.0% | 0.00% | -50.0% |
| Q3 2022 | $1,445,000 | -41.5% | 525,406 | +0.0% | 0.00% | -42.9% |
| Q2 2022 | $2,469,000 | -3.3% | 525,335 | -0.0% | 0.01% | +16.7% |
| Q1 2022 | $2,554,000 | -19.0% | 525,572 | +0.0% | 0.01% | 0.0% |
| Q4 2021 | $3,153,000 | -11.2% | 525,540 | -0.3% | 0.01% | -14.3% |
| Q3 2021 | $3,552,000 | -13.3% | 526,985 | +3.3% | 0.01% | -12.5% |
| Q2 2021 | $4,098,000 | +11952.9% | 510,283 | +16424.7% | 0.01% | – |
| Q4 2020 | $34,000 | +3300.0% | 3,088 | +3712.3% | 0.00% | – |
| Q3 2020 | $1,000 | -100.0% | 81 | -99.9% | 0.00% | -100.0% |
| Q2 2020 | $2,394,000 | – | 111,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |